Applied Ventures helped assay provider Ultivue close a $50m round while clean energy producer Sunseap has followed a $72m series D4 round with more corporate funding.
Funding
US-based multiplex biomarker assay producer Ultivue has closed a $50m series D round featuring Applied Ventures, the investment arm of semiconductor manufacturing equipment producer Applied Materials. The round included Ally Bridge Group, Pura Vida Investments and Tao Capital Partners as well as Arch Venture Partners and Northpond Ventures, both of which took part in Ultivue’s $22m series C round in mid-2019 alongside Applied Ventures, Yonghua Capital and 6 Dimensions Capital, which was co-founded by pharmaceutical firm WuXi AppTec.
…
